Cannitrol – Cannabis Control Agent

Marijuana news from around the world

health care

Cannabis Biopharma Company Enters Fight Over CMS Hemp Pilot

A cannabis biopharma company is seeking to join the federal lawsuit challenging the Centers for Medicare & Medicaid Services’ (CMS) new hemp and CBD pilot program, adding a pharmaceutical voice to a government-sanctioned program allowing untested and unregulated hemp products into the marketplace. MMJ International Holdings and its subsidiaries, MMJ BioPharma Labs and MMJ BioPharma […]

, , , , , , , , , , ,

Are Acidic Cannabinoids the Next Frontier for Product Innovation?

While the cannabis industry has made significant strides in incorporating minor cannabinoids into product formulations, a vast number of therapeutic compounds remain largely unexplored. Researchers and cannabis physicians have been experimenting with acidic cannabinoids for several years with promising results, but the broader industry is only now beginning to catch up. As extraction technologies improve […]

, , , , , , , , , , , , , ,

The Power of AI and How it Will Transform Cannabis Medicine

Biotechnology, cannabis medicine, and the rapid advancements in artificial intelligence (AI) and machine learning (ML) are beginning to converge. Hemant Kumar Bid, program director for the Master of Science in Biotechnology and the Medical Cannabis concentration at Morehouse School of Medicine, believes this convergence could dramatically accelerate the development of cannabis-based therapies. With AI, cannabis […]

, , , , , , , , , , , ,

The Case For Cannabis Telemedicine: Can it Work in the US?

It has been one year since Germany fully legalized cannabis on April 1, 2024, following the launch of its medical program in 2017. While cannabis was removed from the narcotics list, Germany continues to take a medical-first approach. Few expect full adult-use legalization anytime soon, particularly after a conservative government was elected last year. According […]

, , , , , , , , , , ,

Platform Launches Insurance Coverage for Medical Cannabis

A Cleveland-based health-tech company, EM2P2, has launched a platform that could change how Americans pay for medical cannabis. Its new product, CannaLnx, claims to make cannabis care reimbursable, compliant, and accessible by finally allowing patients to apply health-benefit dollars toward cannabis purchases in legal states. Developed as the exclusive tech partner of the American Council […]

, , , , , ,

The Fight For Cannabis and Cancer Research

For decades, cannabis has lived in a research dead zone. Federal prohibition has blocked meaningful grants, limited clinical trials, and left millions of people with cancer relying on anecdotal evidence for treatment rather than data.  As founders of E.R.I.C. Cancer Playbook, we refused to accept that. If institutions didn’t collect the data, patients and the […]

, ,

Platform Launches Promising Insurance Coverage for Medical Cannabis—For Real?

A new health-tech company, EM2P2, has launched CannaLnx, a HIPAA-compliant platform it claims will make medical cannabis reimbursable under traditional health insurance plans for the first time in the U.S. The system, announced in partnership with the American Council of Cannabis Medicine (ACCM), is described as the digital backbone behind ACCM’s “Elevated States” program, which […]

, , , , ,

Colorado leaders plan for the next wave of psychedelic movement

Gov. Polis: “We’re creating pathways for qualified researchers to do research and analysis.”

, , , , , , , , , , , , , , , , , , , , , , , , , ,

Newsom vetoes bill to decriminalize psilocybin ‘magic’ mushrooms, but leaves door open

Newsom’s veto comes despite his overall support for using plant- and fungus-based psychedelic drugs to treat mental illness.

, , , , , , , ,

Colorado’s psychedelic journey begins this week with first advisory board meeting

In mid-March, the state Senate confirmed Gov. Jared Polis’ 15 appointees to the Natural Medicine Advisory Board, a newly formed commission that will advise regulators on the rollout of psilocybin-assisted therapy.

, , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,

Previous Posts